Article
N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
20 Oct 2022
Abstract excerpt
Deregulation of neuroblastoma-derived myc (N-myc) is a leading cause of malignant brain tumors in children. To target N-myc-driven medulloblastoma, most research has focused on identifying genomic alterations or on the analysis of the medulloblastoma transcriptome. Here, we have broadly characterized the translatome of medulloblastoma and shown that N-myc unexpectedly drives selective translation of transcripts...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
